Search - tctmd.com

Displaying 561 - 580 of 724

Sort: Relevancy | Date

Presentation TCT 2013

TCT-62. Preliminary Result of the Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the Maya Medical OneShot™ Ablation System (RAPID) Study.

Presenter: Stefan Verheye

October 29, 2013

Presentation TCT 2013

TCT-61. Optimized External Focused Ultrasound for Renal Sympathetic Denervation – Wave II trial

Presenter: Petr Neuzil

October 29, 2013

Presentation TCT 2013

TCT-60. Clinical and Procedural Outcomes of Renal Artery Denervation In Real World Patients with Hypertension: An Update From the Global SYMPLICITY Registry

Presenter: Felix Mahfoud

October 29, 2013

Presentation TCT 2013

TCT-58. Persistent and Safe Blood Pressure Lowering Effects of Renal Artery Denervation: Three Year Follow-up From the Symplicity HTN-2 Trial

Presenter: Murray Esler

October 29, 2013

News Industry News

New Data from St. Jude Medical Study of EnligHTN Renal Denervation System Presented Today at Scientific Symposium

October 29, 2013

News Industry News

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

October 29, 2013

Presentation TCT 2013

Renal Denervation: Potential in Treating Heart Failure

Presenter: Erwin Blessing

October 28, 2013

Presentation TCT 2013

Trans-ureteral Renal Sympathetic Denervation (Verve Medical)

Presenter: Richard Heuser

October 28, 2013

Presentation TCT 2013

Renal Denervation: Ready for Primetime?

Presenter: Mehdi Shishehbor

October 28, 2013

Presentation TCT 2013

REDUCE-HTN: 6-Month Results from a Prospective Registry Study of Renal Denervation Using a Novel Percutaneous Bipolar Radiofrequency Balloon Catheter in Patients With Resistant...

Presenter: Horst Sievert

October 28, 2013

Presentation TCT 2013

EnligHTN 1: 18-Month Results from a Prospective Registry Study of Renal Denervation in Patients with Resistant Hypertension

Presenter: Stephen Worthley

October 28, 2013

News Conference News TCT 2013

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

October 28, 2013

News Conference News TCT 2013

Preliminary Data Show Potential of Renal Denervation in Several Settings

October 28, 2013

News Industry News

NEW DATA CONTINUE TO SHOW SIGNIFICANT AND SUSTAINED BLOOD PRESSURE REDUCTION WITH BOSTON SCIENTIFIC VESSIX™ RENAL DENERVATION SYSTEM

October 28, 2013

News Conference News TCT 2013

Measuring Response to Renal Denervation Depends on BP Decline, Clinical Relevance

October 28, 2013

News Industry News

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

October 28, 2013

Presentation TCT 2013

Strategies for Measuring Technical Success to Facilitate Ideal Patient Selection in Renal Denervation

Presenter: Paul Sobotka

October 27, 2013

Presentation TCT 2013

Renal Denervation for Glycemic Control and Obstructive Sleep Apnea: An Update

Presenter: Felix Mahfoud

October 27, 2013

Presentation TCT 2013

Ethanol Injection for Renal Denervation (Ablative Solutions)

Presenter: Tim Fischell

October 27, 2013

Presentation TCT 2013

The Spectrum of Current and Future Renal Denervation Clinical Trials

Presenter: Mehdi Shishehbor

October 27, 2013

Advertisement

TCT-62. Preliminary Result of the Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the Maya Medical OneShot™ Ablation System (RAPID) Study.

TCT-61. Optimized External Focused Ultrasound for Renal Sympathetic Denervation – Wave II trial

TCT-60. Clinical and Procedural Outcomes of Renal Artery Denervation In Real World Patients with Hypertension: An Update From the Global SYMPLICITY Registry

TCT-58. Persistent and Safe Blood Pressure Lowering Effects of Renal Artery Denervation: Three Year Follow-up From the Symplicity HTN-2 Trial

New Data from St. Jude Medical Study of EnligHTN Renal Denervation System Presented Today at Scientific Symposium

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

Renal Denervation: Potential in Treating Heart Failure

Trans-ureteral Renal Sympathetic Denervation (Verve Medical)

Renal Denervation: Ready for Primetime?

REDUCE-HTN: 6-Month Results from a Prospective Registry Study of Renal Denervation Using a Novel Percutaneous Bipolar Radiofrequency Balloon Catheter in Patients With Resistant...

EnligHTN 1: 18-Month Results from a Prospective Registry Study of Renal Denervation in Patients with Resistant Hypertension

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

Preliminary Data Show Potential of Renal Denervation in Several Settings

NEW DATA CONTINUE TO SHOW SIGNIFICANT AND SUSTAINED BLOOD PRESSURE REDUCTION WITH BOSTON SCIENTIFIC VESSIX™ RENAL DENERVATION SYSTEM

Measuring Response to Renal Denervation Depends on BP Decline, Clinical Relevance

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

Strategies for Measuring Technical Success to Facilitate Ideal Patient Selection in Renal Denervation

Renal Denervation for Glycemic Control and Obstructive Sleep Apnea: An Update

Ethanol Injection for Renal Denervation (Ablative Solutions)

The Spectrum of Current and Future Renal Denervation Clinical Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content